William A. Haseltine, PhD
Chairman and CEO, Human Genome Sciences, Inc.

William A. Haseltine, Ph.D. is Chairman of the Board of Directors and Chief Executive Officer of Human Genome Sciences, Inc., (HGS), a company he founded in 1992. The mission of Human Genome Sciences, Inc. is to develop products to prevent, treat and cure disease based on its leadership in the discovery and understanding of human genes. Dr. Haseltine holds a doctorate from Harvard University in Biophysics. From 1976 to 1993, he was a Professor at Dana-Farber Cancer Institute, Harvard Medical School and Harvard School of Public Health.

Dr. Haseltine became Chairman and CEO of HGS in 1993. He has a distinguished record of achievement in cancer and AIDS research and has received numerous awards for his scientific work. He is the former Editor-in-Chief of the Journal of AIDS and is the founder and Editor of the on-line journal E-Biomed: A Journal of Regenerative Medicine. Dr. Haseltine has over 250 publications in the scientific literature and has been awarded more than 50 patents for his discoveries. Since 1981 he has founded seven companies, each in a different area of medicine. As a scientific advisor to HealthCare Ventures, he helped to establish an additional 20 biotechnology companies.

Dr. Haseltine joined The Board of the National Health Museum in March, 2000. He served as Chairman of the Board from October, 2000 to March, 2003.